(NASDAQ:VKTX) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and fueled the S&P 500 to record highs. Much of this optimism in the broader ...

智通财经APP获悉，Viking Therapeutics(VKTX.US)宣布，其试验性药物VK2735在较高剂量下相比早期配方能更有效地减轻患者体重，这为其与诺和诺德(NVO.US ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

智通财经APP获悉，Viking Therapeutics(VKTX.US)周一早些时候公布的减肥药VK2735的数据表明，目前主导肥胖药物领域的诺和诺德(NVO.US)和礼来(LLY.US)未来可能 ...

Viking Therapeutics, Inc. (VKTX) closed at $33.69 in the latest trading session, marking a +0.78% move from the prior day. The stock outperformed the S&P 500, which registered a daily gain of 0.53%.

In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against the other multibagger stocks. The US equities continued their upward movement in 2024 and ...